Overview: ACAT Inhibitors: A Potential New Approach to the Treatment of Hypercholesterolaemia and Atherosclerosis
- 1 April 1992
- journal article
- Published by Informa Healthcare in Current Opinion on Therapeutic Patents
- Vol. 2 (4) , 507-526
- https://doi.org/10.1517/13543776.2.4.507
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Synthesis and hypocholesterolemic activity of 6,7-dihydro-4H-pyrazolo[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-diones, novel inhibitors of acylCoA: cholesterol O-acyltransferaseJournal of Medicinal Chemistry, 1991
- Chemical modification of acyl-CoA:cholesterol-O-acyltransferase. 2. Identification of a coenzyme A regulatory site by p-mercuribenzoate modificationBiochemistry, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbitsAtherosclerosis, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Dietary cyclandelate decreases pre-established atherosclerosis in the rabbitAtherosclerosis, 1984
- Solubilization, partial purification, and reconstitution in phosphatidylcholine-cholesterol liposomes of acyl-CoA:cholesterol acyltransferaseBiochemistry, 1982
- Comparative effects of cetaben (PHB) and dichlormethylene diphosphonate (Cl2MDP) on the development of atherosclerosis in the cynomolgus monkeyAtherosclerosis, 1978
- Hypolipidemic alkoxybenzoic acidsJournal of Medicinal Chemistry, 1976
- Metabolism of Linoleamides: I. Absorption, Excretion and Metabolism ofN-(α-Methylbenzyl)linoleamide in Rat and ManXenobiotica, 1976